{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T23:35:38Z","timestamp":1725579338370},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s12664-015-0544-9","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T21:22:07Z","timestamp":1430688127000},"page":"117-126","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transarterial chemoembolization in unresectable hepatocellular carcinoma\u2014assessing the factors affecting the survival: An audit from a tertiary care center in northern India"],"prefix":"10.1007","volume":"34","author":[{"given":"Abhishek","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirenkumar Kamleshkumar","family":"Panwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navneet","family":"Redhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudarsan","family":"Hariprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyush","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,5]]},"reference":[{"key":"544_CR1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693\u20139.","journal-title":"N Engl J Med"},{"key":"544_CR2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/1097-0142(196205\/06)15:3<472::AID-CNCR2820150307>3.0.CO;2-S","volume":"15","author":"B Clarkson","year":"1962","unstructured":"Clarkson B, Young C, Dierick W, et al. Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver. Cancer. 1962;15:472\u201388.","journal-title":"Cancer"},{"key":"544_CR3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Monta\u00f1a X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359:1734\u20139.","journal-title":"Lancet"},{"key":"544_CR4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","volume":"35","author":"CM Lo","year":"2002","unstructured":"Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164\u201371.","journal-title":"Hepatology"},{"key":"544_CR5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiographics.14.3.8066276","volume":"14","author":"DM Coldwell","year":"1994","unstructured":"Coldwell DM, Stokes KR, Yakes WF. Embolotherapy: agents, clinical applications, and techniques. RadioGraphics. 1994;14:623\u201343. quiz 645\u20136.","journal-title":"RadioGraphics"},{"issue":"9 pt 2","key":"544_CR6","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S1051-0443(07)61789-8","volume":"13","author":"DE Ramsey","year":"2002","unstructured":"Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2002;13(9 pt 2):S211\u201321.","journal-title":"J Vasc Interv Radiol"},{"key":"544_CR7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176\u201381.","journal-title":"Semin Radiat Oncol"},{"key":"544_CR8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. J Hepatol. 2001;35:421\u201330.","journal-title":"J Hepatol"},{"key":"544_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"544_CR10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma: an update; American Association for the Study of Liver Diseases. Hepatology. 2011;53:1020\u20132.","journal-title":"Hepatology"},{"key":"544_CR11","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3348\/kjr.2008.9.6.534","volume":"9","author":"SK Ji","year":"2008","unstructured":"Ji SK, Cho YK, Ahn YS, et al. Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization. Korean J Radiol. 2008;9:534\u201340.","journal-title":"Korean J Radiol"},{"key":"544_CR12","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1200\/JCO.2009.23.1282","volume":"27","author":"A Riaz","year":"2009","unstructured":"Riaz A, Ryu RK, Kulik LM, et al. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol. 2009;27:5734\u201342.","journal-title":"J Clin Oncol"},{"key":"544_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","volume":"131","author":"K Takayasu","year":"2006","unstructured":"Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461\u20139.","journal-title":"Gastroenterology"},{"key":"544_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","volume":"29","author":"G Pelletier","year":"1998","unstructured":"Pelletier G, Ducreux M, Gay F, et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol. 1998;29:129\u201334.","journal-title":"J Hepatol"},{"key":"544_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/0971-3026.82294","volume":"21","author":"SB Paul","year":"2011","unstructured":"Paul SB, Gamanagatti S, Sreenivas V, et al. Trans-arterial chemoembolization (TACE) in patients with unresectable Hepatocellular carcinoma: experience from a tertiary care centre in India. Indian J Radiol Imaging. 2011;21:113\u201320.","journal-title":"Indian J Radiol Imaging"},{"key":"544_CR16","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/01.RVI.0000236608.91960.34","volume":"17","author":"CS Georgiades","year":"2006","unstructured":"Georgiades CS, Liapi E, Frangakis C, et al. Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization. J Vasc Interv Radiol. 2006;17:1619\u201324.","journal-title":"J Vasc Interv Radiol"},{"key":"544_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.215.1.r00ap21123","volume":"215","author":"E Caturelli","year":"2000","unstructured":"Caturelli E, Siena DA, Fusilli S, et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology. 2000;215:123\u20138.","journal-title":"Radiology"},{"key":"544_CR18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1148\/radiol.10091473","volume":"255","author":"RJ Lewandowski","year":"2010","unstructured":"Lewandowski RJ, Mulcahy MF, Kulik LM, et al. Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology. 2010;255:955\u201365.","journal-title":"Radiology"},{"key":"544_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-230X-13-60","volume":"13","author":"TC Xue","year":"2013","unstructured":"Xue TC, Xie XY, Zhang L, Yin X, Zhang BH, Ren ZG. Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis. BMC Gastroenterol. 2013;13:60.","journal-title":"BMC Gastroenterol"},{"key":"544_CR20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12072-011-9322-7","volume":"6","author":"IC Lee","year":"2012","unstructured":"Lee IC, Huo TI, Huang YH, et al. Transarterial chemoembolization can prolong survival for patients with metastatic hepatocellular carcinoma: a propensity score matching analysis. Hepatol Int. 2012;6:753\u201362.","journal-title":"Hepatol Int"},{"key":"544_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1440-1746.2010.06341.x","volume":"26","author":"DJ Yoo","year":"2011","unstructured":"Yoo DJ, Kim KM, Jin YJ, et al. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients? J Gastroenterol Hepatol. 2011;26:145\u201354.","journal-title":"J Gastroenterol Hepatol"},{"key":"544_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.0.CO;2-J","volume":"73","author":"RT Poon","year":"2000","unstructured":"Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol. 2000;73:109\u201314.","journal-title":"J Surg Oncol"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-015-0544-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-015-0544-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-015-0544-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T09:49:48Z","timestamp":1559468988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-015-0544-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1007\/s12664-015-0544-9","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}